Oncotarget

Research Papers:

Drug resistance reversal in ovarian cancer cells of paclitaxel and borneol combination therapy mediated by PEG-PAMAM nanoparticles

Liang Zou, Di Wang, Yichen Hu, Chaomei Fu, Wei Li, Liping Dai, Lin Yang _ and Jinming Zhang

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:60453-60468. https://doi.org/10.18632/oncotarget.19728

Metrics: PDF 1908 views  |   HTML 3202 views  |   ?  


Abstract

Liang Zou1, Di Wang1, Yichen Hu2, Chaomei Fu3, Wei Li1, Liping Dai1, Lin Yang1 and Jinming Zhang3

1School of Medicine, Chengdu University, Chengdu 610106, China

2College of Pharmacy and Biological Engineering, Chengdu University, Chengdu 610106, China

3College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China

Correspondence to:

Lin Yang, email: [email protected]

Jinming Zhang, email: [email protected]

Keywords: MDR reversal, co-delivery, P-gp inhibition, PAMAM dendrimer, borneol

Received: May 04, 2017    Accepted: June 10, 2017    Published: July 31, 2017

ABSTRACT

Paclitaxel (PTX) is frequently suffered from multidrug resistance (MDR), resulting in lower chemotherapeutic efficacy and even chemotherapy failure. To combine the P-glycolprotein (P-gp) inhibitor would be a useful strategy to overcome MDR. However, what is needed now is an efficient vehicle to deliver multiple drugs into tumor simultaneously. In this study, PTX and Borneol (BNL), a natural compound with P-gp inhibition effect confirmed in intestinal absorption, were co-loaded in the fabricated PEG-PAMAM nanoparticle (NPs) by a one-step nano-precipitation method with high drug loading efficiency, narrow size distribution and low hemolysis rate. Based on P-gp inhibition activity of BNL, confirmed by drug efflux test and molecular docking model, the combination of PTX and BNL could improve intracellular concentration of PTX in A2780/PTX cells. Furthermore, compared to both free PTX and PTX+BNL, PB/NPs and P/NPs plus BNL exhibited higher cellular uptake and cytotoxicity in A2780/PTX cells, as well as the decreased MMP and enhanced apoptosis rate. More importantly, although PB/NPs and P/NPs+B showed similar tumor accumulation in tumor-bearing mice, PB/NPs could significantly decrease tumor growth of A2780/PTX tumor-bearing mice, in comparison to P/NPs+B. These results indicated the advantage of PTX and BNL co-delivery NPs for MDR reversal. These findings demonstrate that the co-delivery nano-sized system comprised by PEG-PAMAM polymer with PTX and BNL co-loaded would be a promising candidate for MDR treatment.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19728